CClinicalTrials.gg
CompletedNCT03651141Updated Aug 31, 2018

The Effects of Soft Tissue Therapy and Exercise on Hamstring Tightness

An interventional study of Neurodynamic Sliding and Myofascial Decompression in Hamstring Tightness, Myofascial Pain and Musculoskeletal Pain, sponsored by Oklahoma State University. Completed at 1 site in United States. Open to participants aged 18 Years to 25 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2018-08-31.

Sponsored by Oklahoma State University · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Registered 1 year after the study started (first participant enrolled Mar 2017, registered Mar 2018).
Phase
Not applicable
Study type
Interventional
Enrollment
21
Allocation
Randomized
Ages
18 Years to 25 Years
Sex
All
01

Study summary

The purpose of this study is to investigate the effects of myofascial decompression (cupping) and neurodynamic sliding technique for the hamstring on Division I Track and Field athletes who complain of hamstring tightness. Research questions will be: how do these techniques affect hamstring range of motion and flexibility; isometric strength of the hamstring muscle; muscle activation; and rate of force development. The hypotheses of this study are that neurodynamic sliding will have an effect on all variables and myofascial decompression will only have an effect on range of motion.

Read the detailed description

Predisposing factors to hamstring injury include neural tension and muscle flexibility restrictions due to fascial adhesions. The sciatic nerve can produce symptoms of pain, decreased range of motion, and increased resting muscle tone when it is overstretched. The nerve can be overstretched after a hamstring injury and cause adhesions on the nerve and abnormal mechanosensitivity leading to perceived hamstring tightness.The purpose of this study is to investigate the effects of myofascial decompression (cupping) and neurodynamic sliding technique for the hamstring on Division I Track and Field athletes who complain of hamstring tightness. Research questions will be: how do these techniques affect hamstring range of motion and flexibility; isometric strength of the hamstring muscle; muscle activation; and rate of force development. The hypotheses of this study are that neurodynamic sliding will have an effect on all variables and myofascial decompression will only have an effect on range of motion.

02

Conditions studied

  • Hamstring Tightness
  • Myofascial Pain
  • Musculoskeletal Pain

Browse trials for

Keywords

  • Hamstring tightness
  • myofascial decompression
  • cupping
  • neurodynamic sliding
03

In context

Musculoskeletal Pain

493 studies on the registry are indexed under Musculoskeletal Pain; 113 are open to participants now.

This study's enrollment of 21 is below the median of 69 across 346 interventional studies indexed under Musculoskeletal Pain.

Browse Musculoskeletal Pain studies →

Lead sponsor

Oklahoma State University is the lead sponsor of 38 studies on the registry; 5 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 25 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • Must be in the Sprints, Jumps, or Multi (heptathlon, pentathlon, or decathlon) groups
  • complain of hamstring tightness and/or injury in the last calendar year
  • have less than 80⁰ for Active Knee Extension test.

Exclusion criteria

Exclusion Criteria:

  • Past history or current neurological disorders or orthopedic diseases
  • Surgery of the lower extremity that involves an autograft on the tested leg
  • Past history of hamstring surgery
  • Receiving current treatment for a hamstring injury
  • Received any form of myofascial therapy or neurodynamic techniques within the last week unhealed wounds
  • active TB
  • leukemia
  • hemophilia
  • thrombocytopenia
  • fever
  • influenza
  • moderate/severe anemia
  • high blood pressure
  • cardiac conditions
  • late stages of pregnancy
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Factorial assignment
Masking
None (open label)
Enrollment
21 participants (actual)

Study arms

  • Experimental
    Neurodynamic Sliding

    neurodynamic sliding consists of 2 movements; 1) movement 1 involves sitting on the edge of the treatment table the bringing their neck to their chest along with bending their knee and pointing their ankle to the ground. Movement 2 is performed by facing their head towards the ceiling and straightening their knee while pointing their ankle towards their nose. Subjects will alternate these 2 active movements for 60s and repeated 5 times, with rest period of 15s between sets.

    Other: Neurodynamic Sliding

  • Experimental
    Myofascial Decompression

    For the group receiving the cupping treatment, the subject will lay on their stomach and their affected hamstring will be exposed. Cocoa butter will be applied to the hamstring prior to the application of the cups. 5 cups will be placed along the hamstring and calf muscles. Using a handheld suction pump, each cup will be pumped so that skin fills up half of the cup. The cups will stay in place for five minutes and the clinician will instruct the subject to perform 5 repetitions of active quad sets and 5 repetitions of ankle pumps .

    Other: Myofascial Decompression

  • Sham comparator
    Diathermy

    The control group will receive a sham heat (diathermy treatment). The subjects will be asked to sit and relax for five minutes and the machine will not be turned on with a timer timing the treatment.

    Other: Diathermy

Interventions

  • OtherNeurodynamic Sliding

    Subjects in the neurodynamic sliding group perform 2 movements; 1) movement 1 involves sitting on the edge of the treatment table the bringing their neck to their chest along with bending their knee and pointing their ankle to the ground. Movement 2 is performed by facing their head towards the ceiling and straightening their knee while pointing their ankle towards their nose. Subjects will alternate these 2 active movements for 60s and repeated 5 times, with rest period of 15s between sets. A metronome will be set at 30 beats per minute for 15 full slides per minute to standardize the amount of slides per session.

  • OtherMyofascial Decompression

    For the group receiving the cupping treatment, the subject will lay on their stomach and their affected hamstring will be exposed. Cocoa butter will be applied to the hamstring prior to the application of the cups. 5 cups will be placed along the hamstring and calf muscles. Using a handheld suction pump, each cup will be pumped so that skin fills up half of the cup. The cups will stay in place for five minutes and the clinician will instruct the subject to perform 5 repetitions of active quad sets and 5 repetitions of ankle pumps .

  • OtherDiathermy

    The control group will receive a sham heat (diathermy treatment). The subjects will be asked to sit and relax for five minutes and the machine will not be turned on with a timer timing the treatment.

06

What researchers measure

Primary outcomes

  1. Hamstring Flexibility change

    Using the 'Active Knee Extension test', subjects are placed supine with both the hip and knee positioned at 90° of flexion and then asked to extend lower leg until point of limitation. A digital inclinometer is used to measure the angle of the knee joint in this position to examine flexibility of the hamstring muscle group.

    Time frame: Baseline, 5 minutes after intervention, and within 24 hours of intervention

Secondary outcomes

  1. Hamstring muscle strength change

    Peak torque production of the hamstring muscles will be assessed using an isokinetic dynamometer with the subjects performing a maximum voluntary isometric contraction with the knee in a slightly flexed position.

    Time frame: Baseline, 5 minutes after intervention, and within 24 hours of intervention

  2. Time of Force Development

    Time to reach peak force torque

    Time frame: Baseline, 5 minutes after intervention, and within 24 hours of intervention

  3. Electromyographic (EMG) Muscle Activation of the Hamstring muscles

    The electrical activation signaling of the hamstring muscles will be measured using electromyography during the isometric contraction.

    Time frame: Baseline, 5 minutes after intervention, and within 24 hours of intervention

  4. Disablement of the Physically Active patient outcome survey

    The Disablement of the Physically Active Scale (DPAS) paper survey will be used to assess subject perceptions of impairment, limitation, disability and quality of life related to their hamstring discomfort. The scale ranges from 0 (No disability) to 64 (Severe disability) in which the scores will be compared.

    Time frame: Baseline, 5 minutes after intervention, and within 24 hours of intervention

  5. Functional Patient Outcome survey

    The Lower Extremity Functional Scale is a questionnaire containing 20 questions about a subject's ability to perform everyday tasks. Scores range from 0-4 and represent 'extreme difficulty' or 'unable to perform activity' to 'no difficulty'. The maximum score on the survey is 80 points, with lower total scores indicating a greater perceived disability.

    Time frame: Baseline, 5 minutes after intervention, and within 24 hours of intervention

07

Study locations

1 site
  • Applied Neuromuscular Physiology Lab
    Stillwater, Oklahoma 74078, United States
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Aug 31, 2018, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03651141
Lead sponsor
Oklahoma State University
Responsible party
Samantha Wagner (Principal Investigator, Graduate Student, Oklahoma State University) — Principal investigator
First posted
Aug 29, 2018
Start date
Mar 27, 2017
Primary completion
Apr 10, 2017
Completion
Jun 12, 2017
Last update
Aug 31, 2018

Study contacts

Aric Warren, EdD
study chair · Oklahoma State University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Aug 2018. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion